![232 [Anti PDGF Hybridoma #232]](https://www.pda.biobw.org/static/images/cells-no_picture.jpg)
-
平臺編號：bio-68751
-
國際編號：HB-9372?
-
細(xì)胞信息： 232 [Anti PDGF Hybridoma #232]
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
232 [Anti PDGF Hybridoma #232]
生長狀態(tài)：懸浮生長
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG2b
ATCC Number：HB-9372?
數(shù)量：大量
運輸方式：凍存運輸
是否是腫瘤細(xì)胞：0
物種來源：小鼠
規(guī)格：0.5ml Designations: 232 [Anti PDGF Hybridoma #232]
Depositors: ?Amgen, Inc.
Isotype: IgG2b
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against platelet derived growth factor B chain (PDGF B, v-sis form)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Tumorigenic:Yes
Comments:Animals were immunized with affinity purified PDGF B v-sis.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody is specific for the B chain of PDGF v-sis.
Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4.5 g/L glucose, 90%; heat-inactivated fetal bovine serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Preservation: fetal bovine serum, 90%; DMSO, 10%
References: 41495: Thomason AR, Nicolson MA. Methods for purification of platelet-derived growth factor. US Patent 5,175,255 dated Dec 29 1992
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG2b
ATCC Number：HB-9372?
數(shù)量：大量
運輸方式：凍存運輸
是否是腫瘤細(xì)胞：0
物種來源：小鼠
規(guī)格：0.5ml Designations: 232 [Anti PDGF Hybridoma #232]
Depositors: ?Amgen, Inc.
Isotype: IgG2b
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against platelet derived growth factor B chain (PDGF B, v-sis form)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Tumorigenic:Yes
Comments:Animals were immunized with affinity purified PDGF B v-sis.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody is specific for the B chain of PDGF v-sis.
Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4.5 g/L glucose, 90%; heat-inactivated fetal bovine serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Preservation: fetal bovine serum, 90%; DMSO, 10%
References: 41495: Thomason AR, Nicolson MA. Methods for purification of platelet-derived growth factor. US Patent 5,175,255 dated Dec 29 1992
